Pittsburgh Trials Could Be Major Step Toward Curing Diabetes
By Jennifer Bails
TRIBUNE-REVIEW
Monday, March 27, 2006
Children's Hospital of Pittsburgh researchers are expected to receive federal clearance today to inject patients with their own genetically altered immune cells in what could be a major step toward curing type 1 diabetes.
"This is the first time that we can see the light at the end of the tunnel," said Dr. Massimo Trucco, Hillman professor of pediatric immunology at the Oakland hospital, who is leading the preliminary clinical trial approved by the U.S. Food and Drug Administration.
Trucco, a native of Italy who has been hunting for a diabetes cure for more than 20 years, said his research team will be able to determine within six months if the vaccine is safe and then proceed with more extensive trials.
Type 1 diabetes affects about 1.3 million Americans whose lives depend on daily insulin injections.
Read More at the Pittsburgh Tribune Review
Pittsburgh Nation Comments:
Pittsburgh's medical community has a long tradition of lifesaving developments, including curing Polio and performing the world's first double transplant.
Today, Pittsburgh is leading the fight against many diseases using 21st century technologies.
Read more about nanotechnology, regenerative medicine and immunology at UPMC.com.









0 Comments:
Post a Comment
<< Home